Wells Fargo & Company Fibrogen Inc Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Fibrogen Inc stock. As of the latest transaction made, Wells Fargo & Company holds 10,000 shares of FGEN stock, worth $3,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 33,020
69.72%
Holding current value
$3,300
Previous $77,000
89.61%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding FGEN
# of Institutions
111Shares Held
58.2MCall Options Held
2.14MPut Options Held
907K-
Primecap Management CO Pasadena, CA13.7MShares$4.51 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY8.94MShares$2.95 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$1.94 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.36MShares$1.11 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$795,1840.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $30.9M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...